Monotherapy with α-Blocker or Phosphodiesterase 5 Inhibitor for Lower Urinary Tract Symptoms?

被引：2
|
作者：
Chapple, Christopher R. [1 ]
机构：
[1] Sheffield Teaching Hosp NHS Trust, Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England
来源：
EUROPEAN UROLOGY | 2012年 / 61卷 / 05期
关键词：
BENIGN PROSTATIC HYPERPLASIA; ERECTILE DYSFUNCTION; TADALAFIL; SECONDARY; COMBINATION; MANAGEMENT; SILDENAFIL; ALFUZOSIN; SUPERIOR; EFFICACY;
D O I：
10.1016/j.eururo.2012.02.040
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：926 / 927
页数：2
相关论文
共 50 条
  • [1] Combination Therapy with Alpha-blocker and Phosphodiesterase-5 Inhibitor for Improving Lower Urinary Tract Symptoms and Erectile Dysfunction in Comparison with Monotherapy: A Systematic Review and Meta-analysis
    Kallidonis, Panagiotis
    Adamou, Constantinos
    Kotsiris, Dimitrios
    Ntasiotis, Panteleimon
    Verze, Paolo
    Athanasopoulos, Anastasios
    EUROPEAN UROLOGY FOCUS, 2020, 6 (03): : 537 - 558
  • [2] A Meta-Analysis of Long-Versus Short-Acting Phosphodiesterase 5 Inhibitors: Comparing Combination Use With α-Blockers and α-Blocker Monotherapy for Lower Urinary Tract Symptoms and Erectile Dysfunction
    Choi, Hoon
    Kim, Hyun Jung
    Bae, Jae Hyun
    Kim, Jae Heon
    Moon, Du Geon
    Cheon, Jun
    Yeo, Jeong-Kyun
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2015, 19 (04) : 237 - 245
  • [3] Phosphodiesterase type 5 inhibitors in the treatment of low urinary tract symptoms
    Martinez-Jabaloyas, Jose M.
    REVISTA INTERNACIONAL DE ANDROLOGIA, 2009, 7 (03): : 156 - 160
  • [4] Combination alpha blocker and phosphodiesterase 5 inhibitor versus alpha-blocker monotherapy for lower urinary tract symptoms associated with benign prostate hyperplasia: A systematic review and meta-analysis
    Chen, Po-Cheng
    Wang, Chung-Cheng
    Tu, Yu-Kang
    UROLOGICAL SCIENCE, 2020, 31 (03) : 99 - +
  • [5] Phosphodiesterase Type 5 Inhibitor and Erectile Dysfunction in Lower Urinary Tract Symptoms
    Zhao, Chen
    Park, Jong Kwan
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2012, 4 : 75 - 80
  • [6] Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
    Pattanaik, Smita
    Mavuduru, Ravimohan S.
    Panda, Arabind
    Mathew, Joseph L.
    Agarwal, Mayank M.
    Hwang, Eu Chang
    Lyon, Jenifer A.
    Singh, Shrawan K.
    Mandal, Arup K.
    BJU INTERNATIONAL, 2019, 124 (01) : 27 - 34
  • [7] Role of Phosphodiesterase Type 5 Inhibitors for Lower Urinary Tract Symptoms
    Miller, Mindi S.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (02) : 278 - 283
  • [8] MONOTHERAPY FOR COMORBID ERECTILE DYSFUNCTION AND LOWER URINARY TRACT SYMPTOMS: PHOSPHODIESTERASE INHIBITOR OR α-ADRENOCEPTOR ANTAGONIST?
    Wyllie, Michael G.
    BJU INTERNATIONAL, 2012, 109 (07) : 965 - 966
  • [9] Treatment with a Uroselective α1-Blocker Improves Voiding and Sexual Function: A Study in Thai Men with Lower Urinary Tract Symptoms
    Permpongkosol, Sompol
    Krilad-O-Larn, Santichai
    Ratana-O-Larn, Krisada
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 (09) : 2582 - 2589
  • [10] THE EFFICACY OF TADALAFIL 5MG IN THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS IN PATIENTS WHERE ALPHA BLOCKER TREATMENTS HAVE FAILED IN TERMS OF LOWER URINARY TRACT SYMPTOMS
    Atan, Ali
    Polat, Fazli
    Yesil, Suleyman
    Unsal, Ali
    Bulut, Ender Cem
    Tokucoglu, Haluk
    Dojan, Ahmet Emin
    ARCHIVOS ESPANOLES DE UROLOGIA, 2019, 72 (07): : 670 - 676
12345